TrialDiabetes, obesity & metabolism2015

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.

R Chilton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.